Logo image
Antenatal magnesium sulfate for neuroprotection before preterm birth? (editorial)
Editorial   Peer reviewed

Antenatal magnesium sulfate for neuroprotection before preterm birth? (editorial)

Fiona J. Stanley and Caroline Crowther
The New England journal of medicine, Vol.359(9), pp.962-964
2008
PMID: 18753653

Abstract

Preterm infants are at increased risk for serious, lifelong neurologic abnormalities such as cerebral palsy.1,2 As the survival of preterm infants has improved with advances in perinatal care,2 the occurrence of cerebral palsy has increased further, since infants who would previously have died now survive with their cerebral pathology. Currently, more than 30% of children with cerebral palsy are born preterm. Compounding these concerns are the trends, particularly in the United States, to increases in preterm birth.3 An emphasis on improving the survival of very preterm infants without associated strategies to prevent preterm birth or the neurologic disorders associated . . .

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
#5 Gender Equality

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.72 Obstetrics & Gynecology
1.72.924 Preterm Birth Causes
Web Of Science research areas
Medicine, General & Internal
ESI research areas
Clinical Medicine
Logo image